Bettina M. Cockroft
Independent DirectorDr. Bettina M. Cockroft, M.B.A., M.D., is Chief Medical Officer of CILcare S.A.S. Dr. Cockroft has M.D. from Universita' degli Studi di Genova. Dr. Cockroft serves as Independent Director at CNS Pharmaceuticals, Inc. since May 03, 2023. She served as Chief Medical Officer of Sangamo Therapeutics, Inc. since September 2019 until May 2023 and was its Senior Vice President since September 2019 until December 2022. She serves as Independent Director at Annexon, Inc. since January 2022. Dr. Cockroft served as a Vice President of Clinical Research, Neurology at Cytokinetics, Incorporated since August 2017 until September 2019. Dr. Cockroft was Chief Medical Officer at Auris Medical, a biotech company based in Basel developing novel therapeutic approaches to inner ear disorders. She has spent most of her career in Europe leading clinical development programs at several pharmaceutical companies, first at Menarini and its subsidiary Berlin-Chemie in Italy and Germany, followed by Novartis Consumer Health and Merck Serono in Switzerland. She spent long time at Merck Serono working on developing molecules for multiple sclerosis, eventually leading global clinical development for the multiple sclerosis franchise. Dr. Cockroft holds M.D. and trained as a Neurologist at the University of Genova, Italy. Dr. Cockroft has worked in the biopharmaceutical industry and joins Sangamo from Cytokinetics, Inc., where she was a Member of the senior leadership team responsible for clinical development of fast skeletal muscle troponin activators in diseases such as Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy. She also served as Chief Medical Officer at Auris Medical, where she led clinical development programs for hearing disorders. Dr. Cockroft earned her MBA at MIT Sloan School of Management in 2014 and her MD from the University of Genoa.
Positions
- Company NameCNS Pharmaceuticals, Inc.Stock CodeCNSPPositionIndependent DirectorColleagues
- RLRami LevinPresident, CEO & Director
- FLFaith L. CharlesIndependent Chairman of Board
- SOSteve O’LoughlinChief Financial Officer
- EFEric FaulknerChief Technology Officer
- DWDylan WenkeChief Business Officer
- ELE. Lynne KelleyChief Medical Officer
- JRJeffry R. KeyesIndependent Director
- AMAmy MaheryIndependent Director
